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Introduction.There is an established fact thatAsian breast cancer patients are, on average, younger than their European counterparts.
This study aimed to utilize the data from the Cancer Incidence in Five Continents I through XIII (published by the International
Agency for Research on Cancer) to examine what contributes to the younger age at onset in the Asian population. Material and
Methods. Data (number of breast cancer cases and corresponding population figures) for 29 registries in Europe and 9 registries in
Asia for the period of 1953–2002 was accessioned and pooled to form two distinct populations, Asia and Europe. The age specific
rates were defined and analyzed cross-sectionally (period wise) and longitudinally (cohort wise). The magnitude and the pattern
of age specific rates were analyzed using the age-period-cohort analysis. The constrained generalized linear model with a priority
assumption of cohort effect as contributing factor to changing rates was used to analyze the data. Result. During the last 50 years,
the rate of breast cancer increased for both populations with an estimated annual percent change of 1.03% (with 95% CI of 1.029,
1.031) for Asia and 1.016% (95% CI of 1.015, 1.017) for Europe. There were stronger cohort effects in the magnitude of rates among
the Asian population compared to the European population.The cohort effects, expressed as the rate ratio with cohort born in 1970
as reference, ranged from 0.06 (95% CI 0.05, 0.08) to 0.94 (95% CI 0.93, 0.96) for Asians and 0.35 (95% CI 0.33, 0.36) to 1.03 (95%
CI 1.02, 1.04) for Europeans. The estimated longitudinal age specific rates (adjusted for cohort and period effects) showed similar
patterns between the two populations. Conclusion. It was concluded that a strong cohort effect contributes to the younger age at
onset among Asian breast cancer patients.
1. Introduction
Breast cancer is a leading cause of mortality and morbidity
all over the world. In 2008, close to 1.4 million cases were
diagnosed with breast cancer worldwide [1]. The incidence
varies among different populations with high rates seen in
developed countries compared to developing countries [2, 3].
In general, breast cancer rates are highest in white European
and lowest in east Asian populations [1, 4, 5]. The estimated
incidence rate for women living in the south-east Asia region
of World Health Organization’ is 26.1 per 100000 population
and this figure is 89.7 for women living inWestern Europe [1].
The established risk factors of breast cancer are, mainly, early
age at menarche, late age at menopause, nulliparity, number
of live birth, and age at first live birth. Contrary to the large
variations seen in incidence between population of Europe
and Asia, the prevalence of the established risk factors is
not very much different between the two populations [5, 6].
2 ISRN Oncology
A higher risk of breast cancer among American and
European women has been blamed for so-called “western
lifestyle” characterized [7, 8] by the combination of early
menarche, decreased parity, delayed childbearing, and a
sedentary lifestyle. Studies of migrants have confirmed the
relative importance of environment and lifestyle in the
etiology of breast cancer [9–11]. The so-called “western
lifestyle” is now very common in Asian countries such as
Japan, Korea, Taiwan, and Hong Kong and is spreading fast
in the economic booming region of East Asia. In addition
to the major differences in magnitude of rates between
Asians and Europeans, there is a distinct difference in the
shape of age specific rates between the two populations. In
Asian population, the age specific incidence curve peaks at
45–50 and then plateaus and even slightly decreases so that
the rates after 60 years are less than or close to the rates at
age group 45–55. In European population, the age specific
curve increases steadily with no change of pace around
age 50 and the increase continues up to age 80 with a peak
around 65 years. A lower risk and the distinct pattern of age
specific incidence rates among the Asian population (even in
countries with great extent of similar lifestyle with western
population such as Japan, Taiwan, and Hong Kong) have
been a challenging issue among epidemiologists and cancer
scientists to the extent that some have labeled breast cancer
in the population of Asia as a different disease [12]. A recent
symposium in Montreal, Canada, specifically addressing
the same topic, highlighted the younger age at onset as one
of the chief characteristics of breast cancer natural history
in Asian population [12]. What contributes to the peculiar
phenomenon of younger age at onset has been the subject
of inertest to epidemiologists, and it has been hypothesized
that a cohort effect among Asian population causes this
phenomenon. The aim of this study was to use the incidence
rates reported in the Cancer Incidence in Five Continents for
the two populations of Asia and Europe in order to address
the nature of the age specific rate differences between the
two populations using age-period-cohort analysis.
2. Material and Methods
2.1. Patients and Population. Registered cases of female breast
cancer and corresponding person years were ascertained
from the CI5plus, Cancer Incidence in Five Continents Annual
Dataset (an online data repository of International Agency
on Research on Cancer, IARC) for 29 registries in Europe
and 9 registries in Asia for a duration from 1953 to 2002
[13]. Cases from Europe included cases registered for the
period from 1953 to 2002 and cases from Asia included cases
registered for the period from 1963 to 2002. Cases and their
corresponding person years were pooled for each population
to make two distinct populations, referred to hereafter as
Asian and European.
2.2. Statistical Analysis. Descriptive and analytical approach-
es were used to analyse the data. Age specific rates were
addressed both cross-sectionally (period wise) and longitu-
dinally (generational birth cohort wise). For period wise age
specifics, the rates were constructed and described based on
five years period (1955, 1960, 1965, . . . 2000). For the cohort
wise, age specific rates were estimated from age-period-
cohort analysis constructed over each five years cohort. In
addition, the trends in rates expressed as annual percentage
change (APC) and their 95% confidence intervals were
estimated using the age-period-cohort model.
For analytical part, the age-period-cohort model was
used. For this, the periods and cohorts were constructed
in intervals of 5 years. The period included 8 intervals for
Asian population and 10 intervals for European population.
The cohort included 19 intervals for Asian population and 21
intervals for European population. The five-year age groups
were truncated to agemore than 25 years with the last interval
(85 and over) included all cases more than 85 years (13 five-
year age groups were constructed). The constrained gener-
alized linear model (CGLM), the most utilized approach in
the epidemiology literature dealing with age-period-cohort
analysis, was used. For this purpose, a log-linear model with
the general form that includes 𝑎 (age), 𝑝 (period), and 𝑐
(cohort) was applied as follows:
Log {𝜆 (𝑎, 𝑝)} = 𝑓 (𝑎) + 𝑔 (𝑝) + ℎ (𝑐) , (1)
where 𝑎, 𝑝, and 𝑐 represent the mean age, period, and cohort
and 𝑓, 𝑔, and ℎ are parametric functions fitted to the data.
In this model, in addition to estimating the main effect of
age, other components contributing to magnitude of rates
specially the secular changes of rate across study periods
and birth cohorts are estimated. The secular change or net
drift corresponds, interchangeably, to hazard due to period
or cohort, and it has been used to estimate the annual percent
changes of rates over a period of time [14, 15]. As the purpose
of our study was to tackle the difference between the two
populations’ age specific rates, it was assumed that mainly the
cohort effect explains the changing of rates across aging inter-
vals during the study period in both populations. With this
assumption, the model estimates the age function presented
as the log of the age specific rates for the reference cohort
(longitudinal age specific or age specifics across cohorts) and
the cohort effect as log of rate ratio relative to a reference
cohort while period effect constrained to be zero on average
with zero slopes. The estimated logs of age specific rates were
transformed to rate scale (number per 100000 population)
for better realization. In the model, the cohort born during
1970 was considered as the reference cohort and the period of
1970 was considered as the reference period.The longitudinal
age specific raters were estimated and reported for cohort
born on 1885, 1910, 1930, 1950, and 1970. For details of the
modeling please refer to “age-period-cohort models for the
Lexis diagram” by Carstensen [16]. Data were analyzed using
the R 2.14.1 statistical software utilizing Epi 1.1.9 package (R
Development Core Team, 2009).
3. Results
A total of 236,851 cases of breast cancer registered in the 29
European registries and a total of 188,630 cases registered
in the 9 Asian registries were included in the analysis
(Table 4 presents details of the included registries for the two
populations).
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Table 1: Summary statistics of age-period-cohort model for breast cancer rates in European and Asian populations∗.
Model Asia Europe
Df∗∗ Deviance 𝑃 value Df∗∗ Deviance 𝑃 value
Age 514 11764.7 644 45047
Age-drift 513 1920.7 0.000 643 8227 0.000
Age-cohort 509 1628.1 0.000 639 4809 0.000
Age-period 509 1546.2 0.000 639 8118 0.000

























































Figure 1: The cross-sectional age specific rates for both populations.
3.1. Descriptive Approach. There was a constant increasing
of rates for both populations during the last 50 years with
an estimated annual percent of change 1.03 (with 95% CI
of 1.029, 1.031) for Asians and 1.016 (95% CI of 1.015, 1.017)
for Europeans. The incidence rates across all age groups in
Europeans were higher than Asians, especially in older age
groups. During the study period, the magnitude of rates
increased for both populations for each succeeding five-
year period for all age groups. The shape of the age specific
rates (period wise) showed basic differences between the two
populations. For Asian population, the age specific rates for
all periods peaked around 50 years and then decreased and
plateaued afterward (Figure 1). For the European population,
the age specific rates increased up to the last age group for
periods ending 1985 and for the periods after 1985, the age
specific rates peaked between 55 to 75 years and then slightly
decreased (Figure 1).
The fitting of the age-period-cohort model to data indi-
cated that the model that included all the main effects (age,
period, and cohort) has the greatest reduction of deviance,
indicating the best model to explain the observed rates in
both populations; Table 1 presents the goodness of fit of the
models alongwith their parameters.Therewere cohort effects
present in incidence rates of both populations during the
study period; however, the cohort effects in Asians were
much stronger than European. In the Asian population,
the rate ratios presenting the cohort effects ranged from a
low of 0.06 (95% CI 0.05, 0.08) for those born in 1870 to
0.94 (95% CI, 0.93, 0.96) for those born in 1965. In the
European population, the rate ratios presenting the cohort
effect ranged from 0.33 (95% CI, 0.32, 0.35) for cohort born
in 1865 to 1.03 (95% CI, 1.02, 1.04) for the cohort born in
1965 (Table 2 and Figure 2).Therewere residual period effects
in the Asian population around 1975 (rate ratio of 0.89 and
95% CI 0.86, 0.92) and 1985 (rate ratio of 1.12 95% CI of
1.09, 1.13), Figure 2. For both populations, the estimated age
specific rates expressed as longitudinal age specific indicated
the same pattern for both populations; the age specific rates
increased sharply before the age of 50, and the increase
slowed down pace with the last age groups (over 75 years),
still the groups with highest incidence rates. The pattern of
longitudinal age specific rate is presented in Figure 2 along
with the other effects, cohorts, and periods. The estimated











































Figure 2: Estimated effects and their 95% confidence intervals from the age-period-cohort model (breast cancer, age group >25 years, period
1953–2002, and cohort born on 1865–1970 for both European (red) and Asian (blue) populations). Curve in the left represents the estimated
age specific rates for the reference period 1970.Themiddle curve shows the rate ratios of cohort relative to the reference cohort (1970), cohort
effect. The rightmost curves show the rate ratios of period constrained to be zero on average with zero slopes or the residual period effect.
Table 2: The magnitude of cohort effects for the two populations.
Year of birth Rate ratio (95% confidence intervals)
Asia Europe
1865 ∗∗ 0.33 (0.32, 0.35)
1870 0.06 (0.05, 0.08) 0.35 (0.33, 0.36)
1875 0.07 (0.06, 0.09) 0.36 (0.35, 0.37)
1880 0.08 (0.07, 0.10) 0.37 (0.36, 0.38)
1885 0.09 (0.08, 0.11) 0.38 (0.37, 0.40)
1890 0.11 (0.10, 0.12) 0.40 (0.39, 0.41)
1895 0.13 (0.12, 0.14) 0.41 (0.40, 0.42)
1900 0.15 (0.14, 0.16) 0.43 (0.42, 0.44)
1905 0.18 (0.17, 0.19) 0.45 (0.43, 0.46)
1910 0.22 (0.20, 0.23) 0.47 (0.46, 0.49)
1915 0.25 (0.24, 0.27) 0.51 (0.50, 0.53)
1920 0.28 (0.27, 0.30) 0.57 (0.55, 0.58)
1925 0.31 (0.29, 0.33) 0.64 (0.62, 0.65)
1930 0.36 (0.34, 0.38) 0.73 (0.71, 0.75)
1935 0.43 (0.41, 0.46) 0.83 (0.81, 0.86)
1940 0.54 (0.51, 0.57) 0.93 (0.90, 0.96)
1945 0.64 (0.61, 0.68) 1.00 (0.97, 1.03)
1950 0.73 (0.70, 0.77) 1.04 (1.02, 1.07)
1955 0.82 (0.78, 0.85) 1.06 (1.04, 1.08)
1960 0.88 (0.86, 0.91) 1.05 (1.04, 1.07)
1965 0.94 (0.93, 0.96) 1.03 (1.02, 1.04)
1970 1.00 1.0
∗∗No data for Asian population.
and their corresponding confidence intervals are presented
numerically in Table 3 and graphically in Figure 3. As Table 3
and Figure 3 indicate, the estimated age specific rates have
steadily increased in all age groups for both populations























Figure 3: The graphical presentation of the estimated rates for
different generations for both populations (red for Asian and blue
for European).
There is a large difference in the magnitude of rates between
the two populations in early cohort (1890) when they are
compared with the most recent cohort (1970), Table 3 and
Figure 3. The difference in age specific rates between early
and late cohorts is indicative of the cohort effects that cause
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Table 3: The estimated longitudinal age specific rates and corresponding 95% confidence intervals for the two populations for the cohort
born in 1880, 1910, 1930, 1950, and 1970.
Age group 1880 1910 1930 1950 1970
Europe
25 2.3 (2.2, 2.3) 2.9 (2.8, 3.0) 4.4 (4.3, 4.5) 6.3 (6.2, 6.5) 6.1 (5.9, 6.3)
30 7.4 (7.3, 7.6) 9.5 (9.3, 9.7) 14.5 (14.3, 14.8) 20.9 (20.6, 21.1) 20.0 (19.6, 20.5)
35 20.6 (20.3, 20.9) 26.4 (26.1, 26.7) 40.4 (40.0, 40.8) 58.0 (57.6, 58.5) 55.6 (54.2, 57.0)
40 42.6 (41.9, 43.2) 54.5 (54.0, 55.0) 83.5 (82.8, 84.2) 119.9 (119.2, 120.7) 114.9 (111.8, 118.1)
45 68.2 (67.3, 69.2) 87.4 (86.7, 88.0) 133.8 (133.0, 134.6) 192.2 (191.0, 193.3) 184.1 (178.9, 189.5)
50 92.3 (91.0, 93.7) 118.2 (117.4, 119.1) 181.1 (180.1, 182.1) 260.1 (258.1, 262.1) 249.2 (241.9, 256.7)
55 114.1 (112.5, 115.7) 146.1 (145.2, 147.0) 223.8 (222.8, 224.7) 321.3 (318.7, 324.0) 307.9 (298.9, 317.2)
60 134.9 (133.1, 136.8) 172.7 (171.6, 173.8) 264.6 (263.3, 265.8) 379.9 (376.5, 383.5) 364.1 (353.5, 374.9)
65 157.8 (155.7, 159.9) 202.0 (200.9, 203.1) 309.4 (307.9, 311.0) 444.4 (440.2, 448.6) 425.8 (413.5, 438.4)
70 183.6 (181.3, 186.0) 235.1 (233.9, 236.3) 360.1 (357.9, 362.2) 517.1 (512.0, 522.2) 495.5 (481.1, 510.2)
75 212.4 (209.7, 215.1) 271.9 (270.5, 273.4) 416.5 (413.5, 419.5) 598.1 (592.0, 604.3) 573.1 (556.4, 590.3)
80 244.1 (241.2, 247.1) 312.6 (311.0, 314.3) 478.8 (475.2, 482.5) 687.6 (680.5, 694.8) 658.9 (639.5, 678.8)
85 279.7 (276.1, 283.4) 358.2 (355.1, 361.3) 548.6 (543.0, 554.3) 787.8 (778.2, 797.6) 754.9 (732.1, 778.4)
Asia
25 0.4 (0.4, 0.5) 1.2 (1.1, 1.2) 1.9 (1.8, 2.0) 4.0 (3.8, 4.2) 5.4 (5.2, 5.7)
30 1.6 (1.4, 1.8) 4.2 (4.0, 4.4) 6.9 (6.7, 7.1) 14.2 (13.9, 14.6) 19.4 (18.6, 20.2)
35 4.6 (4.0, 5.3) 12.0 (11.7, 12.4) 19.9 (19.4, 20.3) 40.9 (40.3, 41.4) 55.6 (53.1, 58.3)
40 9.0 (7.8, 10.4) 23.7 (23.0, 24.4) 39.1 (38.3, 39.9) 80.4 (79.5, 81.3) 109.5 (103.9, 115.4)
45 13.1 (11.4, 15.1) 34.4 (33.5, 35.4) 56.8 (55.8, 57.8) 116.8 (115.4, 118.3) 159.1 (150.6, 168.2)
50 16.1 (13.9, 18.5) 42.3 (41.2, 43.4) 69.7 (68.6, 70.8) 143.3 (141.0, 145.7) 195.2 (184.4, 206.7)
55 18.7 (16.2, 21.5) 49.1 (47.9, 50.2) 80.9 (79.9, 81.9) 166.5 (163.3, 169.7) 226.7 (214.2, 239.9)
60 21.3 (18.5, 24.5) 55.9 (54.7, 57.2) 92.3 (90.9, 93.6) 189.7 (185.3, 194.3) 258.4 (244.2, 273.5)
65 24.2 (21.0, 27.8) 63.6 (62.4, 64.8) 104.9 (103.2, 106.6) 215.6 (210.4, 221.0) 293.7 (277.4, 310.8)
70 27.6 (24.0, 31.8) 72.7 (71.4, 74.0) 119.9 (117.3, 122.5) 246.5 (239.8, 253.4) 335.7 (316.6, 356.0)
75 32.0 (27.8, 36.8) 84.2 (82.6, 85.7) 138.9 (135.1, 142.7) 285.6 (276.9, 294.6) 388.9 (366.0, 413.3)
80 37.7 (32.8, 43.4) 99.2 (97.3, 101.3) 163.7 (158.7, 168.8) 336.7 (325.4, 348.3) 458.5 (430.7, 488.0)
85 44.9 (39.0, 51.8) 118.2 (113.8, 122.8) 195.0 (186.3, 204.1) 401.0 (382.2, 420.7) 546.1 (508.8, 586.1)
the distinct pattern of age specific rates observed between
the two populations. In addition, comparing the magnitude
of the cohort effects between the two populations (Figure 2),
they indicate that, though, the cohort effects are decreasing
along succeeding cohorts for both populations, but the
decrease in cohort effects in Asians is far larger than those
of Europeans. This difference in decreasing rates of Cohort
effects between the two populations indicates that both
populationsmay experience similar rates in the future if there
are no other major changes to the underlying cause of the
disease in future years.
4. Discussion
Our study proved a steady increase of breast cancer rate with
similar pace during the last 50 years for both populations.
We demonstrated that there is no difference between the
patterns of age specific rates between the two populations
when rates are measured as longitudinal age specific rates.
It was demonstrated that a strong cohort effect contributes
to the differences in pattern of age specific rates between
the two populations. The difference in breast cancer rates
with low rates for Asians versus high rates for Europeans has
been documented since registries in Asia started reporting
population rates [17, 18]. While several studies have demon-
strated marked differences in magnitude and the pattern of
age specific rates among different countries of Europe and
Asia, no study systematically and collectively has addressed
the age specific rate differences in the two populations as
our study did. An overall increasing trend of morbidity from
breast cancer has been reported for all populations of the
world and the increase has been attributed to ageing and
increasing median age of women [15, 17, 19–22]. Our study
showed a very similar increase of incidence between the two
populations.This similarity in slope of increase indicates that
despite the fact that the two populations are basically different
in terms of culture, ethnicity, lifestyle, and social attributes,
the breast cancer epidemic enforces its own pace of epidemic
projection.
Any increase in incidence of breast cancer rates is due
to either changing of risk factors or implementation of mass
screening (especially mammographic screening). Either of
the two can affect both magnitude and pattern of age specific
rates. The difference in the pattern of the age specific rates
between the two populations is well recognized and several
studies have addressed this discrepancy; a study comparing
the shape of the age specific rates between Taiwanese and
Caucasian American reported that the age specific rates of
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Table 4: Detail information about the included registries.




20800 Denmark 1953 49
24600 Finland 1953 49
25001 France, Bas-Rhin 1975 27
25002 France, Calvados 1978 24
25003 France, Doubs 1978 24
25004 France, Haut-Rhin 1988 14
25005 France, Herault 1988 14
25006 France, Isere 1979 23
25007 France, Somme 1983 19
25008 France, Tarn 1983 19
27603 Germany, Saarland 1970 32
38002 Italy, Florence 1985 17
38007 Italy, Parma 1978 24
38008 Italy, Ragusa province 1983 19
38009 Italy, Romagna 1988 14
38010 Italy, Torino 1985 17
38012 Italy, Lombardy, Varese province 1978 24
38020 Italy, Modena 1988 14
52802 The Netherlands, Eindhoven 1973 29
57800 Norway 1953 49
75200 Sweden 1958 44
75602 Switzerland, Geneva 1970 32
75605 Switzerland, St. Gall-Appenzell 1983 19
82603 UK, England, Merseyside, and Cheshire 1975 27
82604 UK, England, north western 1979 23
82605 UK, England, Oxford 1985 17
82609 UK, England, Birmingham, and west Midlands region 1979 23
82610 UK, England, Yorkshire 1983 19
82620 UK, Scotland 1975 27
Asia
34400 China, Hong Kong 1983 19
39203 Japan, Miyagi prefecture 1975 27
39206 Japan, Osaka prefecture 1963 39
39208 Japan, Yamagata prefecture 1983 19
60801 Philippines, Manila 1983 19
70200 Singapore: Chinese 1968 34
70200 Singapore: Malay 1968 34
76401 Thailand, Chiang Mai 1968 34
breast cancer differed between the two populations and the
study concluded that the difference is due to a cohort effect
presented in Taiwanese [23]. Another study comparing breast
cancer rates among populations of Singapore and Sweden
attributed the difference in rates to a large cohort effect and
concluded that this effect will decrease in future generations
causing similar incidence rates between the two population
in coming decades [24]. In addition to comparative studies,
it has been demonstrated that the pattern of age specific
rates for the populations of Japan, Korea, China, Singapore,
Thailand, and Philippine has changed in the recent years
attributing this change to changing of life style toward
more westernization and implementation of mammographic
screening [25]. The pattern and magnitude of age specific
rates of breast cancer have been affected by screening mam-
mography specially in the European population, and this
effect has been mainly presented as increase of incidence
in the age group of 50 to 70 [26–28]. This is compatible
with our finding as it was demonstrated in Figure 1 that age
specific rates for European population increased in that age
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group 50 to 70 and the change happened after 1985 when the
wide spread use ofmammographic screening started [27, 29].
Mammographic screening started in Asia in late 1990 [30, 31]
and its effect on the shape of age specific incidence cannot
be assessed in our study. Compatible with previous studies
comparing the age specific rates of breast cancer between
population of Europe and Asia, our study proved that a
large cohort effect in Asian population rates plays a major
role in the differences in age specific rates between the two
populations.The age specific rates can be defined both cross-
sectionally (period wise) and longitudinally (cohort wise). If
there are no cohort or period effects, the two definitions will
show similar magnitude and pattern of age specific rates. The
distinct pattern of age specific rates (cross-sectional rates)
between the two populations is in fact due to the cohort
effect that was demonstrated in our study. In the other world,
what contributes to the observed pattern of period wise
age specific rates in Asian population is the additive nature
of the cross-sectional definition of age specific rates in the
presence of decreasing cohort effects. Since the rates for two
sequential age groups come from two different cohorts, when
the older cohort has lower risk compared to younger cohort,
the cross sectional patterns of age specifics will decrease. The
strong cohort effect that exists in the Asian breast cancer
is responsible for a distinct pattern of cross-sectional age
specifics seen in the Asian population.
In applying the CGLM model, the choice of constraint
(period or cohort) is based on an external knowledge of the
underlying cause of change of rates in a population. Our
choice of cohort instead of period as constraint was based on
previous studies that attributed the changes of the rates to a
cohort effect [15, 19, 32]. The period effect has been mainly
attributed when change of health policy (e.g., introduction of
more sensitive detection techniques or availability of certain
diagnostic procedures) causes the changing of rates. In the
light of the nature of breast cancer risk factors that are mainly
of hormonal and sociobehavioral nature, their change would
translate on cohort effect than on period effect.
This study enjoyed data of adequate quality as the data
were utilized from the registries that met acceptable degree
of validity and reliability to be published in the International
Agency in Research on Cancer (IARC) official report. In
addition, the quality of the data for both populations is
comparable owing to the efforts and quality assurances and
control protocols that IARC requires for different registries
contributing data to the Cancer Incidence in Five Continents
reports; one may ask. We would have been able to draw
the same conclusion on analyzing just the data of Asian
population without the need of European population. The
main reason for using European for comparison was that
the fact that the specificity attributed to Asian breast cancer
age specific rates has been defined as it has contrasted to the
well-sestablished breast cancer epidemiology in Europe and
western countries.
The methodology we used is a very established and rou-
tine way of analyzing rates at population level when the data
of calendar time exist. The age-period-cohort analysis has
been amajor tool in the hands of demographers and, in recent
decades well utilized by epidemiologists. The methodology,
while very common in use, suffers major problem especially
when it is utilized to attribute the underlying cause of changes
of a rate to period versus cohort (the nonidentifiability
problem). In our study, this problemwas not a concern as our
assumptionwas that the nature of risk factors in breast cancer
would translate into cohort effect other than period effect.
5. Conclusion
It was concluded that no differences in the pattern of age
specific rates exist between the two populations when the age
specifics are measured cohort wise, and the difference seen
in the period wise age specific rate is due to a strong cohort
effect present in the Asian population rates.
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